Physician profile
Daniel C Wilson
NPI 1497250724
$10,468.04
in general payments reported to CMS, 2019-2025
11 companies · $972 in 2025
The $972 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2021: $18.38 · 2023: $3,863 · 2024: $4,851 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,664 · Grant: $3,500 · Food and Beverage: $2,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,664.00 |
| Grant | $3,500.00 |
| Food and Beverage | $2,521.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,583.67 | 2023-2025 | Redapt, Journey II, Or3o Dual Mobility |
| Stryker Corporation | $1,602.50 | 2023-2025 | Mako, Motionsense Digital Goniometer, Triathlon |
| Sequoia Surgical, INC. | $764.08 | 2019 | |
| Alphatec Spine, INC | $194.14 | 2024 | Other - Miscellaneous |
| Orthalign INC | $101.00 | 2023 | Orthalign Plus |
| Innovation Technologies INC | $69.63 | 2025 | Irrisept |
| Boston Scientific Corporation | $49.84 | 2025 | Artisan |
| Bioventus LLC | $34.71 | 2024 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $25.50 | 2025 | Iovera, Zilretta |
| Vertex Pharmaceuticals Incorporated | $24.59 | 2025 | |
| Avanos Medical | $18.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.